The largest database of trusted experimental protocols

Paclitaxel

Manufactured by GoldBio

Paclitaxel is a chemical compound that is widely used in the field of biotechnology and pharmaceutical research. It is a naturally occurring substance derived from the bark of the Pacific yew tree. Paclitaxel is a potent antineoplastic agent, which means it has the ability to inhibit the growth and proliferation of cancer cells. It functions by disrupting the normal cell division process, leading to cell death. Paclitaxel is commonly used in the development and testing of new cancer treatments and therapies.

Automatically generated - may contain errors

4 protocols using paclitaxel

1

Microtubule Polymerization and Stabilization

Check if the same lab product or an alternative is used in the 5 most similar protocols
A polymerization mixture was prepared with BRB80 + 32 μM tubulin + 1 mM GTP + 4 mM MgCl2 + 5% DMSO. The mixture was incubated on ice for 5 min, followed by incubation at 37°C for 30 min. The polymerized microtubules were diluted into prewarmed BRB80 + 10 μM paclitaxel, centrifuged at 110,000 rpm (199,000 × g) in an Airfuge (Beckman-Coulter), and resuspended in BRB80 + 10 μM paclitaxel (99.5+%, GoldBio).
+ Open protocol
+ Expand
2

Paclitaxel-Induced Neuropathic Pain in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rats were given paclitaxel (Cat# P-925–1, Goldbio, Olivette, MO) based on the protocol described by Polomano et al. [63 (link)]. In brief, pharmaceutical-grade paclitaxel (Taxol) was re-suspended at a concentration of 2 mg/ml in 30% 1:1 Cremophor EL: ethanol, 70 % Saline and given to the rats at 2 mg/kg intraperitoneally (i.p.) every other day for a total of 4 injections (days 0, 2, 4, and 6), resulting in a final cumulative dose of 8 mg/kg. No abnormal spontaneous behavioral changes in the rats were noted during or after the treatment. Animals developed mechanical hyperalgesia within 10 days after the first paclitaxel injection.
+ Open protocol
+ Expand
3

Paclitaxel-Induced Neuropathy Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neuropathy with paclitaxel (Cat# P-925–1, Goldbio, Olivette, MO)
was induced with a final cumulative dose of 8 mg/kg using methods described
earlier [60 (link)].
+ Open protocol
+ Expand
4

Microtubule Curvature Analysis with CKAP2

Check if the same lab product or an alternative is used in the 5 most similar protocols
A polymerization mixture was prepared with BRB80 + 32 μM tubulin + 1 mM GTP + 4 mM MgCl2 + 5% DMSO. The mixture was incubated on ice for 5 min, followed by incubation at 37°C for 30 min. The polymerized microtubules were diluted into prewarmed BRB80 + 10 μM paclitaxel, centrifuged at 110,000 rpm (199,000 × g) in an Airfuge (Beckman-Coulter), and resuspended in BRB80 + 10 μM paclitaxel (99.5+%, GoldBio) Curvature Recognition TAMRA labelled paclitaxel microtubules were introduced into flow channels (Bechstedt et al., 2014) . 5 nM CKAP2-mNG in imaging buffer with 10 μM paclitaxel without GTP was introduced into the channel. Quantification of the microtubule curvature, κ, and CKAP2-mNG signal on microtubules was analyzed using Kappa (Mary and Brouhard, 2019) .
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!